Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-19 Purchase(A) | 2022-09-13 4:27 pm | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 138,500 | $3.6103 | $500,020 | 1,160,796 (Indirect Direct) | View |
| 2022-07-19 Purchase | 2022-07-25 7:35 pm | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 138,500 | $3.6103 | $500,020 | 1,160,796 (Indirect Direct) | View |
| 2022-05-10 Sale | 2022-05-12 4:22 pm | Moderna Inc. | MRNA | Nader Francois Director | 3,196 | $136.1 | $434,976 | 37,227 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-06 Option Award | 2024-05-07 5:02 pm | N/A 2034-05-06 | Moderna Inc. | MRNA | Nader Francois Director | 7,557 | $0 | 7,557 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:00 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2023-05-03 Option Award | 2023-05-05 4:14 pm | N/A 2033-05-03 | Moderna Inc. | MRNA | Nader Francois Director | 6,134 | $0 | 6,134 (Direct) | View |
| 2022-07-21 Other(A) | 2022-09-13 4:27 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 386,932 | $0 | 1,160,796 (Indirect) | View |
| 2022-07-21 Other | 2022-07-25 7:35 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 386,932 | $0 | 1,160,796 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-13 6:14 pm | N/A 2032-06-08 | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 14,501 | $0 | 14,501 (Direct) | View |
| 2022-05-10 Exercise | 2022-05-12 4:22 pm | N/A 2029-12-10 | Moderna Inc. | MRNA | Nader Francois Director | 23,100 | $0 | 37,227 (Direct) | View |
| 2022-05-10 Exercise | 2022-05-12 4:22 pm | N/A N/A | Moderna Inc. | MRNA | Nader Francois Director | 23,100 | $18.87 | 37,227 (Direct) | View |
| 2022-04-28 Exercise | 2022-05-02 4:40 pm | N/A N/A | Moderna Inc. | MRNA | Nader Francois Director | 703 | $0 | 6,118 (Direct) | View |
| 2022-04-28 Option Award | 2022-05-02 4:40 pm | N/A N/A | Moderna Inc. | MRNA | Nader Francois Director | 5,415 | $0 | 6,118 (Direct) | View |
| 2021-12-15 Gift | 2021-12-16 4:05 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 59,520 | $0 | 336,167 (Indirect) | View |
| 2021-11-19 Disposition | 2021-11-22 09:06 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 74,483 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:06 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 6,749 | $0 | 0 (Direct) | View |
| 2021-07-21 Disposition | 2021-07-23 4:36 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director | 13,921 | $0 | 0 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:30 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director | 2,635 | $0 | 13,921 (Direct) | View |
Ownership | 2021-05-06 9:18 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 0 | $0 | 477,060 (Direct) | View |
| 2021-04-28 Option Award | 2021-04-30 4:10 pm | N/A 2031-04-28 | Moderna Inc. | MRNA | Nader Francois Director | 4,784 | $0 | 4,784 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:26 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 4,844 | $0 | 9,971 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:12 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 182,447 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:12 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 23,747 | $0 | 0 (Indirect) | View |
| 2020-06-17 Option Award | 2020-06-19 6:36 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-18 5:14 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director | 4,409 | $0 | 11,286 (Direct) | View |
| 2020-04-29 Option Award | 2020-04-30 5:33 pm | N/A 2030-04-29 | Moderna Inc. | MRNA | Nader Francois Director | 18,270 | $0 | 18,270 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 5:37 pm | N/A 2030-01-22 | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 9,562 | $0 | 13,312 (Direct) | View |